3M Completes Acquisition of Ivera Medical Corp.

ST. PAUL, Minn.--(BUSINESS WIRE)-- 3M announced today that it has completed its acquisition of Ivera Medical Corp., a manufacturer of health care products that disinfect and protect devices used for access into a patient’s bloodstream. The business is now a wholly owned subsidiary of 3M and a part of its Critical & Chronic Care Solutions Division.

3M’s vascular access products play an important role in helping to reduce complications for patients with I.V. catheters. The addition of Ivera will enable 3M to bring a broader array of vascular access solutions to more health care systems worldwide.

Ivera’s I.V. port connector caps, sold under the Curos® Brand, are used to disinfect and act as a barrier to contamination on devices that provide access to I.V. lines. These products complement 3M’s vascular access products including Tegaderm™ CHG (Chlorhexidine Gluconate) I.V. Securement Dressings, which deliver the critical elements of antimicrobial protection and securement for I.V. site care.

Ivera is based in San Diego, Calif., employs approximately 60 people and has annual sales of approximately $30 million.

About 3M3M is a science-based company with a culture of creative collaboration that inspires powerful technologies, making life better. With $32 billion in sales, 3M employs 90,000 people worldwide and has operations in more than 70 countries. For more information, visit www.3M.com or follow @3MNewsroom on Twitter.

3M, Tegaderm, and Curos are trademarks of 3M.

Media Contacts:
3M
Lori Anderson, 651-733-0831
or
Kohnstamm Communications
Aaron Berstler, 651-789-1264
or
Investor Contacts:
3M
Matt Ginter, 651-733-8206
or
Bruce Jermeland, 651-733-1807

Source: 3M

You May Also Be Interested In

• Apple (AAPL) announces 'Let Loose,' a special online event to be held in May
• Dryden Gold Intersects 3.17 g/t Gold over 4.00 Meters Including 19.34 g/t Gold over 0.65 Meters at the Gold Rock Camp
• Omdia research handheld gaming devices will reach 29.3 million in 2028